These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 38618195)

  • 1. Probiotics are beneficial for liver cirrhosis: a systematic review and meta-analysis of randomized control trials.
    Yang X; Lei L; Shi W; Li X; Huang X; Lan L; Lin J; Liang Q; Li W; Yang J
    Front Med (Lausanne); 2024; 11():1379333. PubMed ID: 38618195
    [TBL] [Abstract][Full Text] [Related]  

  • 2. L-ornithine L-aspartate for prevention and treatment of hepatic encephalopathy in people with cirrhosis.
    Goh ET; Stokes CS; Sidhu SS; Vilstrup H; Gluud LL; Morgan MY
    Cochrane Database Syst Rev; 2018 May; 5(5):CD012410. PubMed ID: 29762873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Probiotics for people with hepatic encephalopathy.
    Dalal R; McGee RG; Riordan SM; Webster AC
    Cochrane Database Syst Rev; 2017 Feb; 2(2):CD008716. PubMed ID: 28230908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Probiotics for patients with hepatic encephalopathy.
    McGee RG; Bakens A; Wiley K; Riordan SM; Webster AC
    Cochrane Database Syst Rev; 2011 Nov; (11):CD008716. PubMed ID: 22071855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of L-ornithine L-aspartate for minimal hepatic encephalopathy in patients with cirrhosis: A meta-analysis of randomized controlled trials.
    He Q; Mao C; Chen Z; Zeng Y; Deng Y; Hu R
    Arab J Gastroenterol; 2024 May; 25(2):84-92. PubMed ID: 38403493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ursodeoxycholic acid for primary biliary cirrhosis.
    Rudic JS; Poropat G; Krstic MN; Bjelakovic G; Gluud C
    Cochrane Database Syst Rev; 2012 Dec; 12(12):CD000551. PubMed ID: 23235576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of probiotic treatment on cirrhotic patients with minimal hepatic encephalopathy: A meta-analysis.
    Cao Q; Yu CB; Yang SG; Cao HC; Chen P; Deng M; Li LJ
    Hepatobiliary Pancreat Dis Int; 2018 Feb; 17(1):9-16. PubMed ID: 29428113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of probiotics in the treatment of minimal hepatic encephalopathy: A systematic review and meta-analysis.
    Wibawa IDN; Mariadi IK; Shalim CP; Sindhughosa DA
    Clin Exp Hepatol; 2023 Jun; 9(2):146-153. PubMed ID: 37502435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Probiotics for treating eczema.
    Makrgeorgou A; Leonardi-Bee J; Bath-Hextall FJ; Murrell DF; Tang ML; Roberts A; Boyle RJ
    Cochrane Database Syst Rev; 2018 Nov; 11(11):CD006135. PubMed ID: 30480774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Probiotics for management of functional abdominal pain disorders in children.
    Wallace C; Gordon M; Sinopoulou V; Akobeng AK
    Cochrane Database Syst Rev; 2023 Feb; 2(2):CD012849. PubMed ID: 36799531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Probiotics for the prevention of pediatric antibiotic-associated diarrhea.
    Guo Q; Goldenberg JZ; Humphrey C; El Dib R; Johnston BC
    Cochrane Database Syst Rev; 2019 Apr; 4(4):CD004827. PubMed ID: 31039287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacotherapies that specifically target ammonia for the prevention and treatment of hepatic encephalopathy in adults with cirrhosis.
    Zacharias HD; Zacharias AP; Gluud LL; Morgan MY
    Cochrane Database Syst Rev; 2019 Jun; 6(6):CD012334. PubMed ID: 31204790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and Safety of Variable Treatment Options in the Prevention of Hepatic Encephalopathy: A Systematic Review and Network Meta-Analysis.
    Hammd M; Elghezewi A; Abdulhadi A; Alabid A; Alabid A; Badi Y; Kamal I; Hesham Gamal M; Mohamed Fisal K; Mujtaba M; Sherif A; Frandah W
    Cureus; 2024 Jan; 16(1):e53341. PubMed ID: 38435950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Granulocyte colony-stimulating factor with or without stem or progenitor cell or growth factors infusion for people with compensated or decompensated advanced chronic liver disease.
    Colli A; Fraquelli M; Prati D; Casazza G
    Cochrane Database Syst Rev; 2023 Jun; 6(6):CD013532. PubMed ID: 37278488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alterations of gut microbiome and effects of probiotic therapy in patients with liver cirrhosis: A systematic review and meta-analysis.
    Huang L; Yu Q; Peng H; Zhen Z
    Medicine (Baltimore); 2022 Dec; 101(51):e32335. PubMed ID: 36595801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-absorbable disaccharides versus placebo/no intervention and lactulose versus lactitol for the prevention and treatment of hepatic encephalopathy in people with cirrhosis.
    Gluud LL; Vilstrup H; Morgan MY
    Cochrane Database Syst Rev; 2016 May; 2016(5):CD003044. PubMed ID: 27153247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Probiotics for the prevention of Clostridium difficile-associated diarrhea in adults and children.
    Goldenberg JZ; Yap C; Lytvyn L; Lo CK; Beardsley J; Mertz D; Johnston BC
    Cochrane Database Syst Rev; 2017 Dec; 12(12):CD006095. PubMed ID: 29257353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Probiotics for the prevention of pediatric antibiotic-associated diarrhea.
    Goldenberg JZ; Lytvyn L; Steurich J; Parkin P; Mahant S; Johnston BC
    Cochrane Database Syst Rev; 2015 Dec; (12):CD004827. PubMed ID: 26695080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Effects of Probiotics and Symbiotics on Risk Factors for Hepatic Encephalopathy: A Systematic Review.
    Viramontes Hörner D; Avery A; Stow R
    J Clin Gastroenterol; 2017 Apr; 51(4):312-323. PubMed ID: 28059938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.